Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells

Transplantation

Volumn 64, Issue 8, 1997, Pages 1181-1187

  Lehmann, Manfred ^a   Graser, Elmara ^b   Risch, Kirsten ^a   Hancock, Wayne W ^c   Müller, Annett ^a   Kuttler, Beate ^d   Hahn, Hans Jürgen ^d   Kupiec Weglinski, Jerzy W ^e   Brock, Joseph ^a   Volk, Hans Dieter ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; GRAFT SURVIVAL; HEART GRAFT; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; KIDNEY GRAFT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN GRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; GENE EXPRESSION; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RATS, INBRED WF; RNA-DIRECTED DNA POLYMERASE; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 17144450671     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00017     Document Type: Article

References (33)

1. Waldmann H. Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol 1989; 7: 407.
2. Shizuru JA, Gregory AK, Chao CT, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
3. Goldberg D, Morel P, Chatenoud L, et al. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmun 1991; 4: 617.
4. Reinke P, Volk HD, Miller H, et al. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients. Lancet 1991; 338: 702.
5. Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JW. CD4 monoclonal antibodies in organ transplantation: a review of progress. Transplantation 1991; 52: 579.
6. Wood KJ, Pearson TC, Morris PJ. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplant Rev 1991; 5: 150.
7. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 26: 128.
8. Ilano AL, McConnell MV, Gurley KE, Spinelli A, Pearce NW, Hall BM. Cellular basis of allograft rejection in vivo: examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains. J Immunol 1989; 143: 2828.
9. Wang ZQ, Dudhane A, Orlikowsky T, et al. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol 1994; 24: 1549.
10. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. Transplantation 1992; 53: 1281.
11. Kupiec-Weglinski JW, Wasowska B, Papp I, Hancock WW. CD 4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
12. Lowry RP. The relationship of IL-4, IL-10 and other cytokines to transplantation tolerance. Transplant Sci 1993; 3: 104.
13. Banda NK, Bernier J, Kurahara DK, et al. Crosslinking CD4 by HIV gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176: 1099.
14. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Transplantation 1992; 54: 483.
15. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody which suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
16. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 1996; 61: 804.
17. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh M, Kupiec-Weglinski JW. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
18. Stumbles P, Mason D. Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995; 182: 5.
19. Lehmann M, Sternkopf F, Metz F, et al. Induction of long-term survival of rat allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992; 54: 959.
20. Kotzke G, Lehmann M, Kuttler B, et al. The prolongation of skin and islet allograft survival by the application of anti-CD4 monoclonal antibody RIB 5/2. Eur Surg Res 1990; 22: 100.
21. Lehmann M, Kuttler B, Siegling A, et al. Characterization of the anti-CD4-induced permanent acceptance of rat renal allografts. Transplant Proc 1993; 25: 2859.
22. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.
23. Lee S. An improved technique or renal transplantation in the rat. Surgery 1967; 61: 771.
24. Green MK Rat heterotopic heart transplant technique. In: Green MK, Mandel TE, eds. Experimental transplantation models in small animals. Chur, Switzerland: Harwood Academic Publishers, 1995: 267.
25. Billingham RE, Medawar PB. The technique of free skin grafting in mammals. Br J Exp Biol 1952; 28: 385.
26. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel and multispecific competitor for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994; 177: 23.
27. Shizuru JA, Alters SE, Fathman CG. Anti-CD 4 mAb therapy: creation of non-classical tolerance in adults. Immunol Rev 1992; 129: 105.
28. Binder J, Kupiec-Weglinski JW. CD 4 targeted therapy in organ graft recipients. Transplant Sci 1993; 3: 210.
29. Yin D, Fathman CG. Induction of tolerance to heart allografts in high responder rats by combining anti-CD 4 with CTLA4-Ig. J Immunol 1995; 155: 1655.
30. Platzer C, Ode-Hakim S, Reinke P, et al. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994; 58: 264.
31. Del Prete G, De Carli M, Almerigogna F, et al. Human IL-10 is produced by both type 1 helper and type 2 helper T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353.
32. Luqman M, Bottomly K. Activation requirements for CD4+ T cells differing in CD45R expression. J Immunol 1992; 149: 2300.
33. Graser E, Risch K, Linsley PS, et al. Synergism of CTLA4 Ig and anti-CD4 monoclonal antibody treatment in rat kidney transplant model. Transplant Proc 1997; 29: 1307.